We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01612182
First Posted: June 5, 2012
Last Update Posted: June 6, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hoseok Koo, Inje University
  Purpose
The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Condition Intervention
End-stage Renal Disease Other: renal replacement therapy

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Hoseok Koo, Inje University:

Primary Outcome Measures:
  • The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy [ Time Frame: During hospitalization ]
    The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)


Secondary Outcome Measures:
  • The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy [ Time Frame: during hospitalization ]
    The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)


Enrollment: 1289
Study Start Date: March 2012
Study Completion Date: May 2012
Groups/Cohorts Assigned Interventions
ESBL(+) Klebsiella pneumonia
All the patient who's the culture result showed ESBL(+) Klebsiella pneumonia in any site during hospitalization
Other: renal replacement therapy
renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )
ESBL(-) Klebsiella pneumonia
All the patient who's the culture result showed ESBL(-) Klebsiella pneumonia in any site during hospitalization
Other: renal replacement therapy
renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 79 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The patients had admitted in single center
Criteria

Inclusion Criteria:

  • The age of patient was between 18 yrs and 79 yrs.
  • The patient who showed Klebsiella pneumonia in 1st culture result of any site during hospitalization

Exclusion Criteria:

  • The level of serum albumin was below 2.0 or over 5.0
  • The level of AST or ALT was 2 times of normal level or the level of bilirubin was over 2.0 mg/dL during 1month.
  • The level of Body mass index was below 15 or over 30
  • Pregnancy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01612182


Locations
Korea, Republic of
Inje University Seoul Paik hospital Instituional Board Review
Seoul, Je dong 2ga, Jung gu, Korea, Republic of, 100-032
Sponsors and Collaborators
Inje University
  More Information

Responsible Party: Hoseok Koo, Nephrology division, Department of Internal Medicine, Inje University
ClinicalTrials.gov Identifier: NCT01612182     History of Changes
Other Study ID Numbers: ESBL 2012-1
First Submitted: May 29, 2012
First Posted: June 5, 2012
Last Update Posted: June 6, 2012
Last Verified: June 2012

Keywords provided by Hoseok Koo, Inje University:
end-stage renal disease
renal replacement therapy

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency, Chronic
Renal Insufficiency